The DOI matches its Crossref record; 136 of the 138 references it cites were found in a registry or an index.
Metabolism, Activity, and Targeting of D- and L-2-Hydroxyglutarates
Open accessAbstract
Isocitrate dehydrogenases (IDH1/2) are frequently mutated in multiple types of human cancer, resulting in neomorphic enzymes that convert α-ketoglutarate (α-KG) to 2-hydroxyglutarate (2-HG). The current view on the mechanism of IDH mutation holds that 2-HG acts as an antagonist of α-KG to competitively inhibit the activity of α-KG-dependent dioxygenases, including those involved in histone and DNA demethylation. Recent studies have implicated 2-HG in activities beyond epigenetic modification. Multiple enzymes have been discovered that lack mutations but that can nevertheless produce 2-HG promiscuously under hypoxic or acidic conditions. Therapies are being developed to treat IDH-mutant cancers by targeting either the mutant IDH enzymes directly or the pathways sensitized by 2-HG.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Remarkably, almost all IDH1/2 mutations occur in a few unique locations in the active site of the enzymes, which results in the acquirement of a neomorphic enzymatic activity converting α-KG to the oncometabolite D-2-HG118-120.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [119]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251 · cited 1×
“EGLN/PHD-mediated regulation of HIF-1α is the core of ancient oxygen-monitoring machinery used by metazoans from the nematode Caenorhabditis elegans to humans [129].”
BackgroundComprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
The Cancer Genome Atlas Research Network (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402121 · Cited by 3,148
Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875
Self-citationFigueroa, M. E., Abdel-Wahab, O., Lu, C., Ward, P. S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H. F., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.015 · Cited by 2,766
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Noushmehr, H., Weisenberger, D. J., Diefes, K., Phillips, H. S., Pujara, K., Berman, B. P., Pan, F., Pelloski, C. E., Sulman, E. P., Bhat, K. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.017 · Cited by 2,337
Recurring mutations found by sequencing an acute myeloid leukemia genome
Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219
Flagged first, then by citations
2 of the 138 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 243
Pan, B., Hsu, C.-C., Wu, H., Chen, Y.-R., Zhou, X., Wang, S., Li, C., & Lin, H.-K. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01167-1 · Cited by 27
Chinopoulos, C. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.543564 · Cited by 23
Enantioselectivity Effects in Clinical Metabolomics and Lipidomics
Oliveira, R. V., Simionato, A. V. C., & Cass, Q. B. (2021) · Molecules · doi:10.3390/molecules26175231 · Cited by 23
Torrisi, F., D’Aprile, S., Denaro, S., Pavone, A. M., Alberghina, C., Zappalà, A., Giuffrida, R., Salvatorelli, L., Broggi, G., Magro, G. G., et al. (2023) · Antioxidants · doi:10.3390/antiox12020220 · Cited by 25
Tournaire, G., Loopmans, S., Stegen, S., Rinaldi, G., Eelen, G., Torrekens, S., Moermans, K., Carmeliet, P., Ghesquière, B., Thienpont, B., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111105 · Cited by 20
Gromowski, T., Lukacs‐Kornek, V., & Cisowski, J. (2023) · Cancer Cell International · doi:10.1186/s12935-022-02843-0 · Cited by 25
Treatment advances in high-grade gliomas
Chen, X., Cui, Y., & Zou, L. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1287725 · Cited by 22
The landscape of circRNAs in gliomas temozolomide resistance: Insights into molecular pathways
Mafi, A., Hedayati, N., Kahkesh, S., Khoshayand, S., Alimohammadi, M., Farahani, N., & Hushmandi, K. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.05.010 · Cited by 22
Strain, S. K., Groves, M. D., Olino, K. L., & Emmett, M. R. (2019) · Clinical mass spectrometry · doi:10.1016/j.clinms.2019.11.002 · Cited by 21
Zhang, S., Zhang, N., Wan, T., He, Y., Hao, J., Liu, Y., Liu, Y., Chen, B., Zhao, W., Wang, L., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03282-1 · Cited by 22
Glioma-Targeted Therapeutics: Computer-Aided Drug Design Prospective
Poonan, P., Agoni, C., Ibrahim, M. A. A., & Soliman, M. E. S. (2021) · The Protein Journal · doi:10.1007/s10930-021-10021-w · Cited by 20
L-2hydroxyglutaric acid rewires amino acid metabolism in colorectal cancer via the mTOR-ATF4 axis
Tabata, S., Kojima, Y., Sakamoto, T., Igarashi, K., Umetsu, K., Ishikawa, T., Hirayama, A., Kajino‐Sakamoto, R., Sakamoto, N., Yasumoto, K., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02632-7 · Cited by 24
Alteration of Cellular Reduction Potential Will Change 64Cu-ATSM Signal With or Without Hypoxia
Floberg, J. M., Wang, L., Bandara, N., Rashmi, R., Mpoy, C., Garbow, J. R., Rogers, B. E., Patti, G. J., & Schwarz, J. K. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.230805 · Cited by 21
Targeting the Metabolic Adaptation of Metastatic Cancer
Tarragó‐Celada, J., & Cascante, M. (2021) · Cancers · doi:10.3390/cancers13071641 · Cited by 19
Gue, R., & Lakhani, D. A. (2024) · Biomedicines · doi:10.3390/biomedicines12061349 · Cited by 23
Interaction between transforming Theileria parasites and their host bovine leukocytes
Tajeri, S., Haidar, M., Sakura, T., & Langsley, G. (2021) · Molecular Microbiology · doi:10.1111/mmi.14642 · Cited by 19
Mechanisms governing lineage plasticity and metabolic reprogramming in cancer
Perez, L. M., Venugopal, S. V., Martin, A. S., Freedland, S. J., Vizio, D. D., & Freeman, M. R. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.08.001 · Cited by 19
Feng, S., & Liu, Y. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51652-9_18 · Cited by 18
Yang, Y., Li, X., Liu, F., Ma, M., Yang, Y., Ruan, C., Lü, Y., Li, X., Wang, X., Shi, Y., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.174600 · Cited by 19
The Warburg effect drives dedifferentiation through epigenetic reprogramming
Jiang, H., Jedoui, M., & Ye, J. (2024) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2023.0467 · Cited by 17
Tumour metabolites hinder DNA repair
Chen, L., & Xiong, Y. (2020) · Nature · doi:10.1038/d41586-020-01569-1 · Cited by 17
Self-citationAn olive oil phenolic is a new chemotype of mutant isocitrate dehydrogenase 1 (IDH1) inhibitors
Verdura, S., Cuyàs, E., Lozano‐Sánchez, J., Bastidas-Velez, C., Llorach-Parés, L., Fernández‐Arroyo, S., Hernández‐Aguilera, A., Joven, J., Nonell‐Canals, A., Bosch‐Barrera, J., et al. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy159 · Cited by 17
Cheng, Z., Zhang, ., Wang, Z., Song, A., Gao, C., Song, J., Wang, P., Zhang, L., Zhou, Y., Shan, W., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.01.019 · Cited by 17
Self-citationXi, C., Pang, J., Zhi, W., Chang, C., Siddaramappa, U., Shi, H., Horuzsko, A., Pace, B. S., & Zhu, X. (2023) · Blood · doi:10.1182/blood.2022018159 · Cited by 16
Abundance of d ‐2‐hydroxyglutarate in G2/M is determined by FOXM1 in mutant IDH1‐expressing cells
Kancharana, B., Katragunta, K., Sarma, U. M., & Jain, N. (2019) · FEBS Letters · doi:10.1002/1873-3468.13500 · Cited by 16
Deciphering the multifaceted roles and clinical implications of 2-hydroxyglutarate in cancer
Hao, J., Huang, Z., Zhang, S., Song, K., Wang, J., Gao, C., Fang, Z., & Zhang, N. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107437 · Cited by 15
2-hydroxyglutarate rides the cancer-immunity cycle
Foskolou, I. P., Bunse, L., & den Bossche, J. V. (2023) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2023.102976 · Cited by 17
Wei, Z., Ye, S., Feng, H., Zeng, C., Dong, X., Zeng, X., Zeng, L., Xu, L., Liu, Q., & Yao, J. (2022) · Cancer Science · doi:10.1111/cas.15470 · Cited by 14
Yang, J., Chen, X., Jin, S., & Ding, J. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105491 · Cited by 14
Biosensors-Based In Vivo Quantification of 2-Oxoglutarate in Cyanobacteria and Proteobacteria
Chen, H.-L., Latifi, A., Zhang, C., & Bernard, C. S. (2018) · Life · doi:10.3390/life8040051 · Cited by 15
Hammon, K., Renner, K., Althammer, M., Voll, F., Babl, N., Decking, S.-M., Siska, P. J., Matos, C., Cárdenas-Conejo, Z. E., Mendes, K., et al. (2024) · Haematologica · doi:10.3324/haematol.2023.283597 · Cited by 16
Herold, R. A., Schofield, C. J., & Armstrong, F. A. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202309149 · Cited by 12
Muzammal, M., Ali, M., Brugger, B. A., Blatterer, J., Ahmad, S., Taj, S., Shah, S. K., Khan, S., Enzinger, C., Petek, E., et al. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00832-2 · Cited by 20
The oncometabolite L-2-hydroxyglutarate is a common product of dipteran larval development
Mahmoudzadeh, N. H., Fitt, A. J., Schwab, D. B., Martenis, W. E., Nease, L. M., Owings, C. G., Brinkley, G. J., Li, H., Karty, J. A., Sudarshan, S., et al. (2020) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2020.103493 · Cited by 12
TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes
Gurnari, C., Pagliuca, S., Guan, Y., Ademà, V., Hershberger, C. E., Ni, Y., Awada, H. K., Kongkiatkamon, S., Zawit, M., Coutinho, D. F., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021005418 · Cited by 13
Epigenetic regulation of inflammation by CxxC domain‐containing proteins*
Onodera, A., Kiuchi, M., Kokubo, K., & Nakayama, T. (2021) · Immunological Reviews · doi:10.1111/imr.13056 · Cited by 12
Xi, C., Pang, J., Barrett, A., Horuzsko, A., Ande, S., Mivechi, N. F., & Zhu, X. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0935 · Cited by 12
Poonan, P., Agoni, C., & Soliman, M. E. S. (2021) · Chemistry & Biodiversity · doi:10.1002/cbdv.202100110 · Cited by 11
Urine metabolomics analysis of sleep quality in deep-underground miners: A pilot study
Wen, Q., Zhou, J., Sun, X., Ma, T., Liu, Y., Xie, Y., Wang, L., Cheng, J., Wen, J., Wu, J., et al. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.969113 · Cited by 11
Ji, X., Chen, X., Li, H., & Zhang, J. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.06.257 · Cited by 11
Degrading mutant IDH1 employing a PROTAC-based approach impairs STAT3 activation
Dutta, H., & Jain, N. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.110281 · Cited by 10
Fan, Z., Song, H., Qi, M., Wang, M., Bai, Y., Sun, Y., & Yu, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031283 · Cited by 11
Tian, X., Wang, Y., Lu, Y., Wu, B. Y., Chen, S., Du, J. C., Cai, W., & Xiao, Y. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05450-z · Cited by 11
A Förster resonance energy transfer-based d-2-hydroxyglutarate biosensor
Xiao, D., Xu, X., Gao, K., Wang, M., Zhang, W., Lü, C., Wang, X., Wang, Q., Xu, P., Ma, C., et al. (2023) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2023.133681 · Cited by 10
Vike, N. L., Bari, S., Stetsiv, K., Walter, A. E., Newman, S. D., Kawata, K., Bazarian, J. J., Martinovich, Z., Nauman, E. A., Talavage, T. M., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103483 · Cited by 10
Metabolic functions of misunderstood D-2-hydroxyglutarate
Liu, Y., Kang, Z., Zhang, W., Ma, C., Xu, P., & Gao, C. (2024) · The Innovation Life · doi:10.59717/j.xinn-life.2024.100101 · Cited by 10
Devi, D., Sharma, K., Khan, T., Rani, H., Rana, R., Sharma, H., Kaur, P., Prajapati, L., Rizwan, A., Allieu, M., et al. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156271 · Cited by 10
Liu, G., Zhang, S., Qin, H., He, K., Li, R., & Guo, H. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08068-z · Cited by 9
IDH2 mutations in acute myeloid leukemia
Babakhanlou, R., Dinardo, C. D., & Borthakur, G. M. (2023) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2023.2237153 · Cited by 9
Zhang, C., Xiao, J., Fa, L., Jiang, F., Jiang, H., Zhou, L., & Xu, Z. (2023) · BMC Ophthalmology · doi:10.1186/s12886-023-03098-7 · Cited by 9
Uchenunu, O., Zhdanov, A. V., Hutton, P., Jovanović, P., Wang, Y., Andreev, D. E., Hulea, L., Papadopoli, D. J., Avizonis, D. Z., Baranov, P. V., et al. (2022) · FEBS Open Bio · doi:10.1002/2211-5463.13398 · Cited by 9
Gavriil, M., Proietto, M., Paczia, N., Ginolhac, A., Halder, R., Valceschini, E., Sauter, T., Linster, C. L., & Sinkkonen, L. (2023) · Life Science Alliance · doi:10.26508/lsa.202302333 · Cited by 8
Pfefer, T., Bessenyei, A. H., & O'Neill, L. A. J. (2026) · Immunology Letters · doi:10.1016/j.imlet.2026.107153 · Cited by 8
Wen, F., Gui, G., Wang, X., Qin, A., Ma, T., Chen, H., Li, C., & Zha, X. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02482 · Cited by 8
Alam, M. A. U., Khatun, M., & Alam, M. A. U. (2022) · Journal of Food Chemistry and Nanotechnology · doi:10.17756/jfcn.2022-138 · Cited by 8
Oncogenic Mechanisms and Therapeutic Targeting of Metabolism in Leukemia and LymphomaPreprint
Stahl, M. F., Epstein-Peterson, Z. D., & Intlekofer, A. M. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a035477 · Cited by 8
Zhao, Y., Yang, Y. L., Yang, R., Sun, C., Gao, X., Gu, X., Yuan, Y., Nie, Y.-T., Xu, S., Han, R., et al. (2024) · Life Metabolism · doi:10.1093/lifemeta/loae002 · Cited by 8
RNA target-independent non-canonical activation (RINCA) of Cas13 trans-nuclease activity
Liu, W., Zhu, X., Xue, Y., Wang, X., Chang, L., Wang, S., Li, L., Huang, J., Zhang, Y., Cheng, J., et al. (2025) · 中国科学通报：英文版 · doi:10.1016/j.scib.2025.07.015 · Cited by 8
Ambient ionization mass spectrometry in brain cancer diagnosis
Shahi, M., & Cooks, R. G. (2025) · Journal of Mass Spectrometry and Advances in the Clinical Lab · doi:10.1016/j.jmsacl.2025.10.002 · Cited by 7
He, J., Peng, F., Xu, Y., Liu, Z., Su, K., Zhou, Y., Jiang, Y., & Wang, M. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108095 · Cited by 8
Advances in Chiral Metabolomic Profiling and Biomarker Discovery
Pandey, R., & Tiziani, S. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-4116-3_5 · Cited by 7
Li, H., & Tennessen, J. M. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9236-2_10 · Cited by 7
idh-1 neomorphic mutation confers sensitivity to vitamin B12 in Caenorhabditis elegans
Ponomarova, O., Starbard, A. N., Belfi, A. C., Anderson, A. V., Sundaram, M. V., & Walhout, A. J. M. (2024) · Life Science Alliance · doi:10.26508/lsa.202402924 · Cited by 6
Liu, Y., Feng, Z., Zhang, P., Chen, H., Zhu, S., & Wang, X. (2023) · PeerJ · doi:10.7717/peerj.14930 · Cited by 6
Kang, Z., Hou, S., Gao, K., Liu, Y., Zhang, N., Fang, Z., Zhang, W., Xu, X., Xu, R., Lü, C., et al. (2024) · Advanced Science · doi:10.1002/advs.202404119 · Cited by 5
Sugiyama, E., Nishiya, Y., Yamashita, K., Hirokawa, R., Iinuma, Y., Nirasawa, T., Mizuno, H., Hamashima, Y., & Todoroki, K. (2023) · Chemical Communications · doi:10.1039/d3cc01963b · Cited by 6
Ivosidenib in acute myeloid leukemia
Bruzzese, A., Labanca, C., Martino, E. A., Mendicino, F., Lucia, E., Olivito, V., Neri, A., Imovilli, A., Morabito, F., Vigna, E., et al. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2272659 · Cited by 6
Garcia, I., Cornely, K. A., Peterson, C. N., & Berkmen, M. B. (2024) · Essays in Biochemistry · doi:10.1042/ebc20230077 · Cited by 8
Chen, T., Yao, C., Chen, Y., Yuan, C., Lin, C., Hsu, Y.-C., Chuang, P., Kao, C., Li, Y.-H., Hou, H., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02193-1 · Cited by 7
Alberti, G., D’Amico, G., Augello, M. A., Cappello, F., Szychlinska, M. A., Bavisotto, C. C., & Scalia, F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010373 · Cited by 5
Discovery of chirally dependent protein modifications by D- and L-2-hydroxyglutarates
Zhang, Z., Liu, Y.-K., Luo, Z., Wu, M., Evans, C. N., Qu, Z., Xue, F., Wang, Z., Stanciu, L., Zhang, Z., et al. (2026) · Nature Chemistry · doi:10.1038/s41557-026-02093-x · Cited by 7
Mitochondrial l-2-hydroxyglutarate is a physiological signalling metabolite
Chakrabarty, R. P., Vranken, J. G. V., Aoi, Y., Poor, T. A., McElroy, G. S., Vasan, K., Soliman, S. H. A., Iwanaszko, M., Grant, R. A., Howard, B. C., et al. (2026) · Nature · doi:10.1038/s41586-026-10564-x · Cited by 6
Hypoxic pregnancy promotes fibrosis and increases stress metabolites in the ovine fetal liver
McGuckin, M. M., Wang, D., Ortiz, J., Dobrinskikh, E., Tong, W., Botting, K. J., Niu, Y., Giussani, D. A., & Wesolowski, S. R. (2025) · The Journal of Physiology · doi:10.1113/jp288724 · Cited by 8
A genetically encoded biosensor for point-of-care and live-cell detection of d-2-hydroxyglutarate
Liu, Y., Kang, Z., Xu, R., Hou, S., Gong, L., Guo, L., Gao, K., Xu, X., Tan, X., Xiao, D., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62225-8 · Cited by 5
Jóhannsson, F., Árnason, N. Á., Landrö, R., Guðmundsson, S., Sigurjónsson, Ó. E., & Rolfsson, Ó. (2019) · Transfusion · doi:10.1111/trf.15610 · Cited by 5
Maglov, J. M., Feng, M. Y., Lin, D., Barkhouse, K., Alexander, A., Grbić, M., Zhurov, V., Grbić, V., & Tudzarova, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-46589-9 · Cited by 5
Choate, K. A., Konickson, W., Moreno, Z., Brill, O. S., Cromell, B. C., Detienne, B. M., Jennings, M. J., Mann, P. B., Winn, R. J., Kamson, D. O., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-13877-8 · Cited by 5
Immunometabolic Regulation of Anti-Tumor T-Cell Responses by the Oncometabolite D-2-Hydroxyglutarate
Böttcher, M., & Mougiakakos, D. (2019) · Immunometabolism · doi:10.20900/immunometab20190007 · Cited by 4
A Citrate Synthase Splice Variant Rewires the TCA Cycle to Promote Colorectal Cancer Progression
Cheung, J. C. T., Ng, L. W., Zhu, Z., Chen, B., Li, S., Xu, M., Ding, X., Pu, D., Hu, Y., Ren, Y., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-2355 · Cited by 3
Metabolic Vulnerabilities as a Therapeutic Target in Breast Cancer
Guo, S., & Addison, C. (2026) · Current Oncology · doi:10.3390/curroncol33020129 · Cited by 4
Systems metabolic engineering overcomes bottlenecks for high-level L-cysteine production
Zhao, M., Chen, T., Huang, Z., Wu, D., Cao, Y., Zhang, W., & Mu, W. (2026) · Metabolic Engineering · doi:10.1016/j.ymben.2026.05.002 · Cited by 3
Diversity of metabolic features and relevance to clinical subtypes of gliomas
Dasgupta, P., & Puduvalli, V. K. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.03.008 · Cited by 3
Li, X., Bo, Y., Le, L., & Yang, F. (2024) · Journal of Chromatographic Science · doi:10.1093/chromsci/bmae013 · Cited by 3
Both Enantiomers of 2-Hydroxyglutarate Modulate the Metabolism of Cultured Human Neuroblastoma Cells
Gondáš, E., Baranovičová, E., Bystrický, P., Šofránko, J., Evinová, A., Dohál, M., Hatoková, Z., & Murín, R. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04188-8 · Cited by 3
Strain, S. K., Groves, M. D., & Emmett, M. R. (2019) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.8485 · Cited by 3
Inhibition of 2-Hydroxyglutrate Elicits Metabolic-reprograming and Mutant IDH1 Glioma ImmunityPreprint
Kadiyala, P., Carney, S. V., Gauss, J. C., Garcia-Fabiani, M. B., Núñez, F. J., Núñez, F. M., Alghamri, M. S., Liu, Y., Yu, M., Li, D., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.11.086371 · Cited by 3
Isocitrate dehydrogenase 3b is required for spermiogenesis but dispensable for retinal degenerationPreprint
Zhu, S., Huang, J., Xu, R., Wang, Y., Wan, Y., McNeel, R., Parker, E. D., Kolson, D. R., Yam, M., Webb, B. A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.09.479735 · Cited by 3
Ellis, G., Nowak, M. K., Kronenberger, W. G., Recht, G. O., Ogbeide, O., Klemsz, L. M., Quinn, P. D., Wilson, L. S., Berryhill, T. F., Barnes, S., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112776 · Cited by 2
Advances and Future Goals in Acute Myeloid Leukaemia Therapy
Bittar, G., Oliveira-Gomes, D. D., & Rivero, G. (2022) · touchREVIEWS in Oncology & Haematology · doi:10.17925/ohr.2022.18.2.130 · Cited by 2
Jiang, H., Zhang, D., Liu, W., Wang, L., Aleksandrovich, K. D., Chen, X., Zhang, C., Wu, J., Yao, P., Sun, Z., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1238023/v1 · Cited by 2
A bacterial enzyme may correct 2-HG accumulation in human cancers
Yin, W. J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1235191 · Cited by 1
Zhang, M., Liu, Y. J., Lu, X., Du, L., He, N., Song, H., Wang, J., Gu, Y., Yang, M., Xu, C., et al. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31384 · Cited by 1
Development of D2HG biosensors inspired by the molecular mechanism of D2HG regulation of DhdR
Wang, B., Luo, S., & Sun, P. (2025) · Cell chemical biology · doi:10.1016/j.chembiol.2025.10.004 · Cited by 1
Liu, C.-T., Su, Y., Chiang, N., Li, C.-F. L., Ma, Y., Chang, K., Hung, Y.-H., Hung, W.-C., & Chen, L. (2026) · Cancer Research Communications · doi:10.1158/2767-9764.crc-25-0591 · Cited by 1
Zhou, N., Fei, F., Tang, L., Zhang, P., Wang, W., Zheng, B., Shen, Q., Yue, J., Huang, L., Du, Y., et al. (2026) · Cancer Discovery · doi:10.1158/2159-8290.cd-25-0643 · Cited by 1
Zhao, X.-P., Mai, C.-T., Zhao, Y., Zhou, X.-Y., Lai, N.-H., Zhang, X.-J., & Fan, X. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189590 · Cited by 1
Papaneophytou, C. P., & Petrou, C. C. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl49369 · Cited by 1
Connection between Warburg Effect and Oncometabolites Biosynthesis with its Clinical Implications
Szlasa, W. (2020) · Organic and Medicinal Chemistry International Journal · doi:10.19080/omcij.2020.09.555771 · Cited by 1
Taub, M. L. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.108992 · Cited by 1
Dowdy, T., & Larion, M. (2026) · Methods · doi:10.1016/j.ymeth.2026.08.005 · Cited by 1
Metadata
- Authors
- Ye, D., Guan, K.-L., & Xiong, Y.
- Affiliations
- Shanghai Medical College of Fudan University (CN)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Ye, Dan
- Xiong, Yue
- Venue
- Trends in Cancer
- Publisher
- Elsevier BV
- Published
- 2018-02
- Volume
- 4
- Issue
- 2
- Pages
- 151-165
- ISSN
- 2405-8025 (ISSN-L)
- 2405-8033
- PMC
- PMC5884165
- OpenAlex
- W2782192099
- Cited by
- 242
- References
- 138
- Citations by year
- 2026: 26 · 2025: 31 · 2024: 23 · 2023: 28 · 2022: 30 · 2021: 38 · 2020: 29 · 2019: 25 · 2018: 11
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Trends in cancer (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion, cc-by-nc-nd)
- PubMed Central (acceptedVersion, cc-by-nc-nd)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc-nd)
- Funders
- National Key R&D Program of China (2016YFA0501800)
- NSFC (81522033, 81372198)
- Shanghai Committee of Science and Technology (16JC1404000)
- NIH (CA196878, GM51586, CA063834, CA163834)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Biochemical Acid Research Studies
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Keywords
- 2-hydroxyglutarate, IDH mutation, IDH1, IDH2, alpha-ketoglutarate, epigenetic demethylation, histone demethylation, DNA demethylation, hypoxia, acidosis
- MeSH terms
- Animals, Glutarates, Humans, Isocitrate Dehydrogenase, Mutation, Neoplasms, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
